NASDAQ · IMCR

Immunocore Holdings PLC American

$35.00 -$0.51 (-1.44%) 1D After hours
Charting by TradingView

Key Metrics

$1.81B
Market cap
—
P/E · TTM
$412.81M
Revenue · TTM
−$27.57M
Net income
EPS · TTM $-0.53
Dividend yield —
Free cash flow −$30.75M
Beta · 1Y 0.65
EBITDA · TTM −$8.72M
Gross margin —

Snapshot

Market cap$1.81B
Enterprise value—
Shares outstanding50.9M
52-wk range$27.56 – $40.71
Avg volume · 20D308.8K
Net cash —
Book value / share$7.58
IndustryBiological Products, (No Diagnostic Substances)
ExchangeNASDAQ
About Immunocore Holdings PLC American
IPO dateFeb 5, 2021
Employees524

Immunocore Holdings PLC is a commercial-stage biotechnology company.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S4.38
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—

Profitability

Gross —
Operating -2.9%
Net -6.7%
FCF -7.4%
ROE / ROIC -7.3% · 6.1%

Financial Health

Current ratio4.18
Quick ratio4.15
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$763.69M

Cash Flow · TTM

Operating CF −$24.92M
Capex −$5.82M
Free cash flow −$30.75M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings